Income from operations was RMB3.4 billion (US$489.2 million) in the third quarter of 2024, representing an increase of 46.7% from RMB2.3 billion in the third quarter of 2023 and an increase of 633.4% ...

As a special session on the interdisciplinary scientific development of the 2024 Pujiang Innovation Forum organized by the ...

These remarkable results highlighted our rapidly growing brand influence and users’ strong recognition of our advancements in intelligentization. As our vehicle deliveries continue to grow, we are ...

Feeding in aquaculture is a highly time-consuming task, and overfeeding often leads to additional costs and poor water quality. To address these issues, ITRI has developed a precision feeding decision ...

To help improve a company’s competitive edge in the optoelectronic industry and nurture information service providers’ big data analyzing capabilities, ITRI has been devoted to developing prognostic ...

These remarkable results highlighted our rapidly growing brand influence and users’ strong recognition of our advancements in intelligentization. As our vehicle deliveries continue to grow ...

As a result of their work, Huawei and its partners around the world able to provide differentiated digitalization solutions helping its clients to accelerate the overall “intelligentization ...

To B/ To H Business Growth: Case sharing and demonstration of carriers, sharing how to achieve to B/ to H business success through UBB network innovation. UBB Network Monetization: In the AI era, UBB ...

“进博会作为中国对外开放的窗口，也为我们提供了一个展示自身创新成果和国际化布局的绝佳舞台。”复星医药董事长吴以芳十分感慨地说，以创新为发动机、国际化为 驱动力 ( 7.950, 0.67, 9.20%) ，复星医药走过30年发展历程，专注于未满足的临床需求，引入了多款创新药械落地中国，也助推中国创新成果走向全球。